CYMABAY THERAPEUTICS INC's ticker is and the CUSIP is 23257D953. A total of 3 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,677,634 | +14.5% | 155,700 | -27.7% | 0.01% | -9.1% |
Q3 2023 | $3,213,105 | +20859.6% | 215,500 | +15292.9% | 0.01% | – |
Q2 2023 | $15,330 | -88.8% | 1,400 | -91.1% | 0.00% | – |
Q1 2023 | $136,904 | +1719.6% | 15,700 | +1208.3% | 0.00% | – |
Q4 2022 | $7,524 | +88.1% | 1,200 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -66.7% | 1,200 | -71.4% | 0.00% | – |
Q2 2022 | $12,000 | -14.3% | 4,200 | -6.7% | 0.00% | – |
Q1 2022 | $14,000 | -53.3% | 4,500 | -50.0% | 0.00% | – |
Q4 2021 | $30,000 | -73.9% | 9,000 | -71.4% | 0.00% | – |
Q3 2021 | $115,000 | -37.5% | 31,500 | -25.2% | 0.00% | – |
Q2 2021 | $184,000 | -5.2% | 42,100 | -1.6% | 0.00% | – |
Q1 2021 | $194,000 | +6.6% | 42,800 | +35.0% | 0.00% | – |
Q4 2020 | $182,000 | -53.0% | 31,700 | -71.4% | 0.00% | -100.0% |
Q2 2020 | $387,000 | +1282.1% | 110,900 | +670.1% | 0.00% | – |
Q4 2019 | $28,000 | 0.0% | 14,400 | +161.8% | 0.00% | – |
Q3 2019 | $28,000 | -36.4% | 5,500 | -9.8% | 0.00% | – |
Q2 2019 | $44,000 | -17.0% | 6,100 | +52.5% | 0.00% | -100.0% |
Q1 2019 | $53,000 | -1.9% | 4,000 | -41.2% | 0.00% | – |
Q4 2018 | $54,000 | -11.5% | 6,800 | +23.6% | 0.00% | – |
Q3 2018 | $61,000 | +1933.3% | 5,500 | +2650.0% | 0.00% | – |
Q2 2018 | $3,000 | -98.4% | 200 | -98.6% | 0.00% | -100.0% |
Q1 2018 | $187,000 | +26.4% | 14,400 | -10.6% | 0.00% | +100.0% |
Q4 2017 | $148,000 | +7300.0% | 16,100 | +7950.0% | 0.00% | – |
Q3 2017 | $2,000 | -33.3% | 200 | -60.0% | 0.00% | – |
Q2 2017 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 39,900 | $347 | 0.00% |
GROUP ONE TRADING LLC | 15,700 | $136,904 | 0.00% |